4,000-Patient study aims to uncover hidden causes of heart valve disease
NCT ID NCT07065500
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is following 4,000 people with heart valve disease to look for new substances in the body (called metabolites) that might be linked to the disease. Researchers hope to find better ways to predict who will get worse and understand why. No new treatments are being tested—this is about gathering information to guide future research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward new ways to predict or manage valvular heart disease.
- What could go wrong
- This is an observational study, not a treatment trial. It may identify risk factors but won't directly test a therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VALVULAR HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Sun Yat-sen Univerity
RECRUITINGGuangzhou, Guangdong, 510000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Prepping the body before heart surgery: could exercise shorten hospital stays?
- New flowchart could reduce ICU time and pacemakers after TAVR
- Nutrition check before heart surgery may flag lung risks in seniors
- AI-Powered patch could replace ultrasound for heart checkups
- Heart signal test could spot valve disease faster
- Heart valve repair devices under 5-Year safety spotlight